Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Small molecule approaches for promoting neurogenesis.

Frank M Longo1, Tao Yang, Youmei Xie

  • 1Department of Neurology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA. longof@neurology.unc.edu

Current Alzheimer Research
|February 14, 2006
PubMed
Summary

Small molecules that promote neurogenesis offer new therapeutic avenues for neurological disorders. Continued research and high-throughput screening are key to discovering novel compounds and mechanisms for neurogenesis enhancement.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alzheimer's disease biological domain sub-stratification enhances the precision of functional analyses.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Mapping cross-domain drivers of Alzheimer's disease risk through integrated network analysis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Plasma proteomics reveals divergent sex-specific senescence and bone biology signatures across neurodegenerative diseases.

bioRxiv : the preprint server for biology·2026
Same author

Taming the "death receptor": translating the first-in-class p75<sup>NTR</sup> modulator LM11A-31 from basic biology, across broad preclinical models, to clinical proof-of-concept.

Journal of translational medicine·2026
Same author

Nerve growth factor receptor p75NTR interacts with Toll-like receptor 4 and the alarmins high mobility group box 1 and nucleophosmin: a novel inflammatory mechanism in psoriasis.

The British journal of dermatology·2026
Same author

Small molecule modulation of the p75 neurotrophin receptor promotes dendritic spine resilience to pathogenic tau species and reduces their accumulation.

Acta neuropathologica communications·2026

Area of Science:

  • Neuroscience
  • Pharmacology
  • Drug Discovery

Background:

  • Neurogenesis, the formation of new neurons, plays roles in learning, memory, and brain repair.
  • Small molecules offer a promising avenue for modulating neurogenesis for therapeutic benefit.

Purpose of the Study:

  • To explore the potential of small molecules in promoting neurogenesis.
  • To identify novel therapeutic strategies targeting neurogenesis in both physiological and pathological conditions.

Main Methods:

  • Review of current small molecule discovery approaches for neurogenesis.
  • Categorization of compounds based on their mechanisms of action (e.g., pathway modulators, growth factor mimetics, existing drugs).
  • Emphasis on unbiased, high-throughput screening for novel compound and mechanism discovery.

Related Experiment Videos

Main Results:

  • Small molecules can target various stages of neurogenesis, including precursor proliferation, survival, migration, and maturation.
  • Diverse classes of compounds show potential, including pathway modulators, growth factor mimetics, existing drugs, hormones, and neurotransmitter receptor agents.
  • High-throughput screening is expected to yield new active compounds and uncover novel regulatory mechanisms.

Conclusions:

  • Small molecule-driven neurogenesis promotion holds significant therapeutic potential for neurological diseases.
  • Identifying specific molecular targets and mechanisms for precursor cells remains a critical challenge for clinical translation.